Sonio in the news

Cécile Brosset led the 85 million euro sale of her fetal ultrasound AI startup to Samsung Medison, focusing on job creation and maintaining French R&D.

Sonio launched four new ultrasound device packages to improve maternal care diagnostics and operational efficiency by integrating with existing systems and addressing common technology issues.

Sonio introduced an AI-driven product suite to improve maternal healthcare workflows and diagnostics across U.S. clinics and health systems.

Sonio introduced a four-tier AI-driven ultrasound workflow platform to improve prenatal care quality and efficiency for US maternal care providers.

New ultrasound software packages aim to improve diagnostic accuracy and streamline maternal care workflows in the U.S.

Sonio develops AI-driven prenatal ultrasound software with strong cybersecurity measures, FDA clearances, and tools to improve prenatal diagnosis and care quality worldwide.

FDA cleared Sonio Suspect AI module improves ultrasound detection of fetal anomalies by 22%, aiding clinicians in prenatal diagnosis.

The US FDA cleared Sonio Suspect, enhancing fetal anomaly detection accuracy by 22 points and enabling early detection from 11 weeks.

FDA cleared Sonio's Sonio Suspect AI module, improving early prenatal anomaly detection from 69% to 91%.

Sonio Suspect AI cleared by FDA improves fetal anomaly detection accuracy and enables earlier diagnosis during prenatal ultrasounds.

Sonio introduced Sonio Voice, an AI voice recognition tool that automates real-time ultrasound reporting to improve efficiency and accuracy in OB-GYN practices.

Sonio introduced Sonio Voice, an AI-powered voice-recognition tool to streamline ob-gyn ultrasound reporting by transcribing and inputting data in real-time.

Sonio is a prenatal ultrasound software developed from academic research, recently acquired by Samsung to enhance diagnostic capabilities and expand globally.

Samsung finalized a $92.4 million deal to acquire Sonio, a French startup specializing in AI-driven software for OB/GYN ultrasound scans.

Sonio, an AI-driven prenatal diagnostic start-up, was acquired by Samsung Healthcare to expand its innovative fetal anomaly detection solutions globally.

Sonio, a prenatal ultrasound diagnostic software startup founded by Cécile Brosset, was sold to Samsung Medison for around 85 million euros.

Samsung bought French AI ultrasound startup Sonio for 86 million euros, keeping it independent to enhance medical imaging technology.

Samsung Medison acquired French AI startup Sonio, which develops prenatal ultrasound interpretation software, to advance global prenatal diagnostics.

Sonio, a French AI-driven prenatal ultrasound medtech, was acquired by Samsung Medison for 85 million euros to enhance global pregnancy monitoring and diagnostics.

Samsung Medison is acquiring Sonio SAS to integrate AI into fetal ultrasound systems, enhancing prenatal care workflows and outcomes.